LLY vs TRT · P/E 39, rev $22.97B vs P/E 294, rev $16.5M
Eli Lilly and Company (LLY) versus Trio-Tech International (TRT) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Trio-Tech International (TRT) is a semiconductor equipment & materials company listed on AMEX.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported TRT revenue for 2026-03-31 was $16.5M. Net income was -$38.0K. Revenue was down 47.0% from 2025-12-31 to 2026-03-31. TRT currently screens at market cap $148.7M and trailing P/E 294.0.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. TRT currently screens at market cap $148.7M and trailing P/E 294.0.
Not investment advice. Open the LLY and TRT stock pages for the full models.
Not investment advice.